arrow
M

Marcin Cieślik

university of michigan
H指数:54
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets

整合蛋白质组学和代谢组学分析急性髓系白血病以识别分子亚型及相关治疗靶点

2026-06-120
OA
The hematopoietic stem cell MYB enhancer is essential for and recurrently amplified during Tcell leukemogenesis

造血干细胞MYB增强子对于T细胞白血发生至关重要且在其过程中反复扩增

2026-01-020
OA
Author Correction: Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

作者更正: 癌症SLC43A2改变T细胞甲硫氨酸代谢和组蛋白甲基化

Nature
IF48.5
2025-12-120
OAAI
Balance between STAT5 and STAT3 determines dendritic cell function and tumor immunity
2025-11-010
PRE
Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastoma

染色体不稳定性会破坏高危神经母细胞瘤中对于抗GD2免疫治疗效果所必需的发育表型。

2025-09-260
OAAI
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures

不同种族和暴露因素下肺腺癌的整合分析

2025-07-310
OAAI
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity

STAT5和STAT3的平衡塑造了树突状细胞功能及肿瘤免疫。

NATURE
IF48.5
2025-05-140
OA
Hi-C Allows Genome-Wide Characterization of Enhancer-Driven Oncogene Rearrangements in Formalin-Fixed Lymphoid Cancer Biopsies

Hi-C允许对甲醛固定的淋巴瘤癌活检样本中增强子驱动的癌基因重排进行全基因组表征

BLOOD
IF23.1
2024-11-050
PRE
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
2024-10-010
OAAI
CDK12 loss promotes prostate cancer development while exposing vulnerabilities to paralog-based synthetic lethality
2024-06-100
PRE
Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis
2024-05-211
OAAI
Comprehensive proteogenomic characterization of rare kidney tumors

罕见肾肿瘤的综合蛋白质基因组学特征

2024-05-013
OAAI
Proteogenomic and metabolomic characterization of acute myeloid leukemia
2024-03-220
PRE
Genome instability in renal tumors
2024-03-220
PRE